๐Ÿ•ต๏ธ Allarity Therapeutics, Inc. ($ALLR)

SEC insider & ownership activity, last 12 months ยท CIK 1860657 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. No red-flag 8-Ks in the window.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Shareholder vote (5.07)Jun 26, 2026 filing โ†—
Other events (8.01)Jun 26, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 26, 2026 filing โ†—
Other events (8.01)Jun 18, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 18, 2026 filing โ†—
Officer/director changes (5.02)May 27, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 27, 2026 filing โ†—
Reg FD disclosure (7.01)May 8, 2026 filing โ†—
Other events (8.01)May 8, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 8, 2026 filing โ†—
Other events (8.01)May 5, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 5, 2026 filing โ†—
Other events (8.01)Apr 27, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 27, 2026 filing โ†—
Other events (8.01)Apr 21, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 21, 2026 filing โ†—
Earnings (2.02)Mar 31, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 31, 2026 filing โ†—
Other events (8.01)Mar 6, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 6, 2026 filing โ†—
Material agreement (1.01)Mar 2, 2026 filing โ†—
New financial obligation (2.03)Mar 2, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 2, 2026 filing โ†—
Other events (8.01)Feb 18, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Feb 18, 2026 filing โ†—
Other events (8.01)Feb 3, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Feb 3, 2026 filing โ†—
Material agreement (1.01)Jan 28, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jan 28, 2026 filing โ†—
Unregistered equity sale (3.02)Dec 23, 2025 filing โ†—